Development of potent neuromedin U receptor agonists
An De Prins(Vrije Universiteit Brussel), Steven Ballet(Vrije Universiteit Brussel), Mette M. Rosenkilde(University of Copenhagen), Ann Van Eeckhaut(Vrije Universiteit Brussel), Csaba Tömböly(HUN-REN Szegedi Biológiai Kutatóközpont), Vicky Caveliers(Universitair Ziekenhuis Brussel), Charlotte Martin(Vrije Universiteit Brussel), Ilse Smolders(Vrije Universiteit Brussel), Birgitte Holst(University of Copenhagen)
VUBIR (Vrije Universiteit Brussel)
September 8, 2016
Cited by 0
Related Papers
International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
|Pharmacological Reviews|2013|849
GPR39 Signaling Is Stimulated by Zinc Ions But Not by Obestatin
|Endocrinology|2006|432
Agonists and Inverse Agonists for the Herpesvirus 8-encoded Constitutively Active Seven-transmembrane Oncogene Product, ORF-74
|Journal of Biological Chemistry|1999|185
Pharmacokinetics of oral and intravenous melatonin in healthy volunteers
|BMC Pharmacology and Toxicology|2016|179
In Vivo Characterization of High Basal Signaling from the Ghrelin Receptor
|Endocrinology|2009|121